The Central Drugs Standard Control Organisation (CDSCO) has issued an urgent directive to all state and Union Territory drug controllers to stop the manufacturing and marketing of certain unapproved Fixed Dose Combination (FDC) drugs.
This concerns the reports of the export of unapproved combination drugs containing Tapentadol and Carisoprodol by the Mumbai-based pharmaceutical company to certain West African nations.